SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-22-006884
Filing Date
2022-06-21
Accepted
2022-06-21 15:17:26
Documents
12

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 2999646
2 GRAPHIC g336249g01a03.jpg GRAPHIC 66185
3 GRAPHIC g336249g01a22.jpg GRAPHIC 47246
4 GRAPHIC g336249g01a35.jpg GRAPHIC 53365
5 GRAPHIC g336249g01a36.jpg GRAPHIC 81463
6 GRAPHIC g336249g01b22.jpg GRAPHIC 50804
7 GRAPHIC g336249g01c22.jpg GRAPHIC 49625
8 GRAPHIC g336249g01d22.jpg GRAPHIC 73267
9 GRAPHIC g336249g02a18.jpg GRAPHIC 75732
10 GRAPHIC g336249g10s06.jpg GRAPHIC 111045
11 GRAPHIC g336249g16a55.jpg GRAPHIC 89005
12 GRAPHIC g336249g97c67.jpg GRAPHIC 108622
  Complete submission text file 0000950123-22-006884.txt   4084150
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2AQ 011 44 1786 430411
LumiraDx Ltd (Filer) CIK: 0001685428 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-06232 | Film No.: 221027860
SIC: 2834 Pharmaceutical Preparations